The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
J Neuropsychiatry Clin Neurosci 19:326-330, August 2007
doi: 10.1176/appi.neuropsych.19.3.326
© 2007 American Neuropsychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Maggi, J. D.
* Articles by Halman, M. H.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Maggi, J. D.
* Articles by Halman, M. H.
Related Collections
* AIDS/HIV
* Other Treatment

The Effect of Divalproex Sodium on HIV Replication In Vivo

Julie D. Maggi, M.D., M.Sc., F.R.C.P.(C.) and Mark H. Halman, M.D., F.R.C.P.(C.)

Received April 4, 2006; revised September 3, 2006; accepted September 26, 2006. Drs. Maggi and Halman are affiliated with St. Michael’s Hospital, Mental Health Service, and the Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. Dr. Halman is also affiliated with St. Michael’s Hospital, Centre for Research in Inner City Health, and St. Michael’s Hospital, The Keenan Research Centre in the Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada. Address correspondence to Dr. Maggi, Room 17-033, Cardinal Carter Wing, St. Michael’s Hospital, 30 Bond Street, Toronto, ON M5B 1W8; maggij{at}smh.toronto.on.ca

In vitro data suggest valproate activates HIV replication. This study prospectively assesses whether divalproex sodium causes an increase in HIV replication in patients. Eight participants had their HIV viral load measured over approximately 1 month. The largest increases in viral load occurred in patients without antiretroviral medication. No patients had an increase in Log10 HIV viral load ≥0.5. Further study is needed to understand implications.







Get information about faster international access.

Privacy Policy

Copyright © 2007 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org